| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T92 |
124-201 |
Sentence |
denotes |
Lopinavir/ritonavir was administered at the dosage of 400/100 mg for 14 days. |
| T93 |
202-281 |
Sentence |
denotes |
The primary time-to-event endpoint was clinical improvement from randomization. |
| T94 |
282-670 |
Sentence |
denotes |
In the primary study population (ITT), no statistically significant differences were observed with regard to the primary endpoint of clinical improvement (HR 1.24 with standard of care as reference, 95% CI 0.90 to 1.72) and the secondary endpoint of 28-day mortality (19.2% vs. 25.0% in investigational and comparator arms, respectively; percentage difference −5.8%, 95% CI −17.3 to 5.7). |
| T95 |
671-824 |
Sentence |
denotes |
In the mITT population, lopinavir/ritonavir led to a median time to clinical improvement that was shorter by 1 day than that observed with standard care. |
